Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.8B | 6.0B | 6.0B | 6.2B |
Cost of revenue | 3.5B | 3.7B | 3.7B | 3.9B |
Gross profit | 2.3B | 2.3B | 2.2B | 2.2B |
Operating expense | ||||
Research & development | 760.7M | 769.7M | 711.0M | 713.2M |
Selling general and admin | 996.3M | 1.2B | 987.6M | 981.1M |
Other operating expenses | — | — | — | — |
Operating income | 499.0M | 257.6M | 515.1M | 498.4M |
Non operating interest income | ||||
Income | — | — | — | 1.9M |
Expense | 17.2M | — | — | — |
Other income expense | -254.7M | 36.3M | -177.1M | -251.3M |
Pretax income | 227.1M | 277.8M | 324.1M | 248.9M |
Tax provision | 38.3M | -1.6B | 43.0M | 59.0M |
Net income | 188.7M | 1.9B | 281.1M | 189.9M |
Basic EPS | 0.3 | — | 0.5 | 0.3 |
Diluted EPS | 0.3 | — | 0.5 | 0.3 |
Basic average shares | 696.5M | — | 693.2M | 694.6M |
Diluted average shares | 714.4M | — | 711.5M | 713.2M |
EBITDA | 596.3M | 170.2M | 799.8M | 787.1M |
Net income from continuing op. | 188.7M | 1.9B | 281.1M | 189.9M |
Minority interests | 1.2M | 21.4M | 2.6M | 5.4M |
Preferred stock dividends | — | — | — | — |